Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.
Kelley C. O’donnell, Jim Grigsby, Charles S. Grob
Am J Psychiatry January 1, 2025 DOI: 10.1176/appi.ajp.20230785 via PubMed
Summary
AI-generated from the abstractA comprehensive review argues that psychedelic-assisted psychotherapy research should expand beyond clinical efficacy to include potential harms, diverse patient experiences, and ethical integration. The authors advocate for a balanced approach that examines both therapeutic benefits and risks, emphasizing humility in interpreting findings. They call for broader investigation into how context, patient diversity, and responsible integration shape outcomes, rather than focusing solely on symptom reduction. The review highlights the need to address challenges such as adverse effects, cultural appropriation, and equitable access to ensure the full impact of these treatments is understood.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Promising treatments Therapeutic power Research scope |
| Citations | 9 |
| Key finding | Psychedelic-assisted psychotherapy research must expand its scope to include harms, diverse patient experiences, and ethical integration for a balanced understanding of its therapeutic power. |
Abstract
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.